抗瘤剂诱导的便秘:一个系统的审查
Agnès Calsina-Berna1,2,3, Jesús González-Barboteo3,4, Silvia Llorens-Torromé3,4
1Palliative Care Department, School of Medicine, The University of Vic-Central University of Catalonia (UVIC-UCC), 08500 Vic, Spain.
Cancers
|January 11, 2024
概括
抗瘤剂引起的便秘 (ATAIC) 的患病率差异很大. 需要进一步的研究,以了解其原因,并开发有效的神经保护治疗这种常见的副作用.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 便秘是接受抗瘤治疗的患者经常出现的不良反应.
- 导致抗瘤剂诱导便秘 (ATAIC) 的确切机制尚不清楚.
- 了解ATAIC对于改善癌症治疗期间患者的生活质量至关重要.
研究的目的:
- 系统地审查和综合有关ATAIC的流行,病因和治疗的现有文献.
- 识别有关ATAIC的当前知识的差距.
- 为未来的研究方向提供基础.
主要方法:
- 根据PRISMA指南进行了全面的系统审查.
- 包括的研究以英语,法语或西班牙语出版,重点关注患有癌症的人类受试者.
- 数据提取涵盖了ATAIC的流行率,病因因素和治疗干预措施.
主要成果:
- 审查中包括了73篇文章.
- 报告的ATAIC患病率差异很大,从0.8%到86.6%,其中六项研究的患病率超过50%.
- 高度便秘 (3级和4级) 范围从0%到11%. 针,益生菌和moxibustion等治疗方法显示出有前途.
结论:
- 在接受抗瘤治疗的患者中,便秘的患病率高度可变.
- 需要进行精心设计的研究,专门报告抗瘤治疗引起的便秘的患病率.
- 神经保护被强调为管理化疗诱导的胃肠道疾病的潜在治疗策略,强调肠道神经元完整性的作用.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
170
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
170
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
205
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
205
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Drugs for Treatment of Diarrhea-Predominant IBS
176
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
176
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
218
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
218
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
203
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
203


